Walleye Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-221,982
| Closed | -$8.7M | – | 2435 |
|
|
2024
Q4 | $8.7M | Buy |
221,982
+117,022
| +111% | +$4.59M | 0.02% | 300 |
|
|
2024
Q3 | $4.13M | Buy |
+104,960
| New | +$4.13M | 0.01% | 496 |
|
|
2024
Q1 | – | Sell |
-5,054
| Closed | -$233K | – | 3022 |
|
|
2023
Q4 | $233K | Sell |
5,054
-120,974
| -96% | -$5.57M | ﹤0.01% | 1445 |
|
|
2023
Q3 | $4.31M | Buy |
126,028
+36,324
| +40% | +$1.24M | 0.01% | 421 |
|
|
2023
Q2 | $3.45M | Sell |
89,704
-15,628
| -15% | -$602K | 0.01% | 377 |
|
|
2023
Q1 | $3.77M | Buy |
105,332
+18,815
| +22% | +$673K | 0.06% | 359 |
|
|
2022
Q4 | $3.41M | Sell |
86,517
-1,454
| -2% | -$57.3K | 0.06% | 334 |
|
|
2022
Q3 | $3.18M | Sell |
87,971
-73,956
| -46% | -$2.67M | 0.06% | 306 |
|
|
2022
Q2 | $4.93M | Buy |
161,927
+7,619
| +5% | +$232K | 0.14% | 171 |
|
|
2022
Q1 | $4.72M | Buy |
154,308
+82,324
| +114% | +$2.52M | 0.13% | 164 |
|
|
2021
Q4 | $2.25M | Buy |
+71,984
| New | +$2.25M | 0.07% | 295 |
|
|
2018
Q3 | $101K | Buy |
+7,647
| New | +$101K | 0.05% | 235 |
|